Introduction
Abnormalities in myocardial blood flow, despite angiographically normal coronary arteries, have been reported in a large number of cardiovascular disorders such as congestive heart failure, hypertensive heart disease, dilated and hypertrophic cardiomyopathies and syndrome X. More recently, similar abnormalities have also been reported in patients with ischaemic heart disease in myocardial regions remote from coronary stenosis.
To explain these findings, three main factors have been considered: perturbation in central haemodynamics leading to a relative decrease in coronary driving pressure, particularly in subendocardial layers [1] ; myocardial hypertrophy leading to both microvascular compression and to a relative discrepancy between the number of vessels and the volume of the myocardial cells [2] and, finally, spasm in large coronary arteries [3] . However, considerable evidence has now been collected challenging this interpretation. Flow abnormalities, often associated with clinical and electrocardiographic signs of ischaemia, have been observed in the absence of any of the factors mentioned above [4] . For this reason, an hypothesis of the existence of primary abnormalities at the level of the coronary microcirculation -either anatomical or functionalhas been put forward by several authors [4, 5] . To date, evaluation of the coronary microcirculation in patients is hampered by a number of methodological limitations. As a consequence, although the coronary microvasculature is suspected of being involved in a large number of clinical syndromes, its nature and mechanisms remain largely speculative.
In this paper, we will not review the large number of observations supporting the hypothesis of microvascular involvement in different cardiovascular diseases [6] but rather discuss the available techniques for studying microcirculation in the clinical setting. More specifically, this paper will try to identify the most appropriate technique to answer specific research questions about the anatomy and function of the coronary microcirculation. Table 1 outlines the overall structure of the paper, listing the research questions and the relative methodologies available that can be used to answer those questions.
Anatomy of coronary microcirculation Direct visualization of microvessels
Histological examination of cardiac autopsy specimens has been the basic tool for nosographic classification of a large variety of structural vascular alterations in human pathology [7, 8] . Today, additional associated tools, such as morphometry, electron microscopy and histochemistry should also be considered. However, in spite of the fact that cardiac catheterization, cardiac surgery and heart transplantation have extended histological investigation to cardiac tissue samples obtained during life, the information obtained so far by direct approach has been limited, especially in relation to diseases that are the topic of this review. This is not surprising if one considers that the anatomical structure of the intramural coronary tree, the laws governing its development, its method of branching, size and number of vessels are still largely undetermined. Thus, to detect quantitative rather than qualitative changes, even by direct inspection, is a difficult task, since the microcirculatory alterations might involve the number and size of myocytes, the size of the vessels relative to the branching level they belong to, and the volume and content of the perivascular and interstitial space.
In addition, endomyocardial biopsy is not risk free and is limited by the fact that it is mostly performed in the right ventricle and provides tissue samples in number and size too small to disclose regional alterations. Larger transmural samples can be obtained during cardiac surgery; however, this approach can be used only in those diseases that require surgery [9] . Finally, cardiac transplantation allows the examination of the entire heart but limits the observation to end-stage diseases. In brief, the following are the histological findings of hypertension, cardiomyopathies, syndrome X and ischaemic heart disease.
In patients with dilated cardiomyopathy or syndrome X [1, 10] , no specific microvascular alterations were documented on cardiac biopsy. In autopsy studies of myocardial hypertrophy, several authors [11, 12] reported an abnormal narrowing of small coronary arteries, with a prevalence ranging from 15 to 45% of tissue samples analysed. In hypertensive patients, endomyocardial biopsy permitted an abnormally high media/lumen ratio of the coronary microvessel to be identified. In a study by Schwartzkopf and co-workers, the hypertrophied vascular wall of hypertensive patients was remodelled [13] , with thickened media and a reduced vascular lumen, associated with increased perivascular fibrosis. Interestingly, in these patients, this phenomenon was closely correlated with an increase in minimal coronary resistance, documented by inert gas measurements of maximal flow capacity.
As far as ischaemic heart disease is concerned, atherosclerotic lesions, similar to those observed in subepicardial branches, have only been reported in particular forms of hyperbetalipoproteinaemia (type II or type IV familial hyperbetalipoproteinaemia) [14] . An autopsy study [15] reported alterations in the vasculature. A pattern was first observed in the presence of focal fibrosis and severe occlusive disease of epicardial coronary arteries: a plexus or mesh of dilated small arteries, arterioles and capillary-like vessels (running parallel to the myofibres), together with radial dilated, large branching arteries supplying the plexus. By contrast, in the presence of confluent fibrosis, large vessels predominated and ran in a circumferential or diagonal direction, with many anastomoses. Finally, in dense scar tissue, an avascular pattern was observed. These vascular alterations were consistently associated with myocardial fibrosis and, thus, were interpreted by the authors as the final time-dependent effect of ischaemic heart disease.
Indirect evaluation of microvascular anatomy
Anatomical alterations in coronary microvasculature may produce, as a final effect, an increase in coronary resistance, which in turn may be responsible for myocardial ischaemia, even in the absence of coronary stenosis. On this basis, functional measurement of coronary flow and in particular of minimal coronary resistance, may reflect structural changes of microvessels. This is true provided that the increase in resistance due to large coronary arteries is excluded, that all functional factors reducing vascular lumen at any level of the coronary tree have been removed and, finally, that increased resistance is not related to tissue compression of otherwise anatomically normal vessels.
Minimal coronary resistance
Minimal coronary resistance is defined as the resistance to flow of a maximally vasodilated coronary vasculature. During maximal vasodilation, provided that all vessels are opened up, coronary blood flow is linearly related to arterial pressure [16] . The slope value of the correlation line between pressure (X axis) and flow (Y axis) represents maximal conductance that is the inverse of minimal coronary resistance (Fig. 1A) . To obtain this value, maximal vasodilation as well as simultaneous measurement of coronary blood flows and arterial pressures are needed. 
Review 1301
Several methods and agents have been proposed to maximally vasodilate the coronary arterial bed, i.e. transient coronary occlusion [17] , papaverine [18] , adenosine [19] and dipyridamole [18] . Coronary occlusion has frequently been used in dog experiments; however, several studies documented that this approach does not always induce maximal vasodilation [20] . In humans, the use of this technique is hampered by a number of ethical and methodological considerations. Obviously, the experimental occlusion of a normal coronary artery is not possible in humans, while this procedure can be performed in stenotic segments during coronary angioplasty. In this setting, a major limitation is the difficulty in assessing the actual impact of a residual epicardial stenosis on overall coronary resistance. From a theoretical point of view, this limitation might be overcome by the simultaneous measurement of blood flow [21] and pressure downstream of the epicardial obstruction [22] . Papaverine has widely and safely been used as a maximal coronary vasodilator in patients with coronary artery disease [18] , syndrome X [23] or hypertension [24] . Since this drug requires direct intracoronary injection, it has mainly been used during Doppler monitoring of intracoronary flow velocity. Similar results have been obtained by intracoronary injection of adenosine [19, 25, 26] ; nevertheless, care must be taken not to inject this agent into a coronary artery supplying the sinus node or the atrioventricular node; this may cause a block. In a manner different from papaverine, adenosine can be intravenously injected and used for non-invasive evaluation of maximal coronary blood flow.
Another agent widely employed in the clinical setting is dipyridamole. This drug has been safely used for non-invasive evaluation of maximal blood flow with a variety of methods [18, 27] . Nevertheless, its use in the basic evaluation of minimal 'anatomical' resistance has not been conclusively ascertained. In fact, the adequate dose for maximal vasodilation is still a matter of controversy (0·56 mg . kg 1 or 0·84 mg . kg 1 of body weight). In addition, in a recent study, it has been demonstrated that under certain circumstances (e.g. in syndrome X patients) high dose dipyridamole submaximally vasodilates coronary circulation [28] . It should be noted that with adenosine injection the coronary vascular wall is exposed to a high concentration of short acting exogenous adenosine, while with dipyridamole the structures are exposed to progressively accumulating endogenous adenosine.
The major question with all of these methods is whether the elicited vasodilation is really maximal. In an animal study [20] , we demonstrated that a prolonged continuous infusion of adenosine induced a much larger vasodilation than that usually observed with an adenosine bolus injection, post-ischaemic reactive hyperaemia or papaverine administration. Although this observation has so far not been investigated in humans, this phenomenon might suggest that, in disagreement with common opinion, maximal vasodilation is not achieved with currently used protocols.
The appropriate vasodilator agent for a minimal resistance study should be chosen bearing all the mentioned limitations in mind. Additionally, measurement of minimal coronary resistance requires an accurate simultaneous measurement of coronary blood flow and arterial pressure. In the clinical setting, measurements of blood flow changes from baseline to 'maximal' are frequently used to explore the coronary reserve [16] ; however, this procedure does not provide conclusive insight into minimal coronary resistance. By definition, during maximal vasodilation, blood flow is linearly related to arterial pressure. In a diagram where the X axis represents pressure and the Y axis flow, the lower the value of minimal resistance the steeper the regression line becomes. As a consequence, small differences in arterial pressure cause large differences in blood flow (Fig. 1B) . To overcome this potential drawback, several authors proposed an index of coronary resistance obtained as the ratio between mean arterial pressure and corresponding flow [29] . This method takes into account differences in aortic pressure; nevertheless, it still represents only an approximation. Using this ratio, it is assumed that the force moving the flow into the coronary circulation is the pressure gradient between the aorta and the coronary sinus. Since, under most conditions, the latter value is around zero, it can be neglected and the relationship can be written as
where F is flow, P is aortic pressure and R the anatomical resistance. However, several studies demonstrated that blood flow ceases even when driving pressure is higher than the pressure in the coronary sinus [30] . On the basis of this observation, it has been hypothesized that the force moving the coronary blood flow might be the pressure gradient between the aorta and myocardial tissue. In this line, the concept of a waterfall model has been developed [31] . This model, applied to coronary circulation by Downey and Kirk [31] , states that the pressure -flow relationship in the coronary circulation during maximal vasodilation is:
where F is flow, P is perfusion pressure, Pe the tissue pressure and R the anatomical resistance. When P decreases at a value equal to Pe in a critical segment of the vascular tree the vessel collapses and flow stops ( Fig. 2) . Taking into account these considerations, minimal coronary resistance should be calculated by using multiple measurements of coronary blood flow at different levels of arterial pressure. As a possible solution to this problem, the modification of arterial pressure by infusion of vasoactive drugs has been proposed [32] . Another more recent approach is the analysis of the pressureflow velocity relationship in a single diastole, using phasic blood flow monitoring provided by Doppler catheters [33] . Unfortunately, both techniques are hampered by a number of artefacts. The difficulty of the first approach lies in the fact that the majority of drugs used for modifying arterial pressure may affect coronary resistance as well. Moreover, reflex activation of the autonomic nervous system might affect such a relationship by altering haemodynamics, contractility chamber size and thus wall tension. To solve this problem, the study should be performed under autonomic blockade, although this adds complexity to the study protocol. On the other hand, the single beat model is strongly affected by the problem of vascular capacitance [34] [35] .
Vasomotion
Coronary vasomotion has been studied in a large number of in vivo and ex vivo animal models. The recent introduction of methods able to visualize Review 1303 microcirculation in the beating heart and to measure diameter and plasma or red cell velocities in single microvessels has greatly enhanced our knowledge of microvascular tone regulation [35] . Unfortunately, the large majority of these methods cannot be applied in man. Nevertheless, by simultaneously assessing the response of myocardial blood flow and epicardial vessel diameter to a variety of agents, the vasomotor tone of coronary microvessels can be defined in an accurate way, mainly when alterations in blood flow cannot be explained by changes in the calibre of large arteries. With such a technique, indirect conclusions can be drawn about the mechanisms regulating the coronary microcirculation in humans.
Direct evaluation of changes in vessel diameter can be obtained in man by quantitative angiography or intracoronary echo. However, these techniques explore only epicardial vessels no smaller than 0·5-2 mm in diameter.
As an example of the use of coronary angiography to obtain indirect information on microcirculation, Wilson et al. [4] observed the occurrence of ischaemia associated with a low run-off of contrast medium, immediately after coronary angioplasty in patients with unstable angina and intracoronary thrombus. Since they could not measure any trans-stenotic gradient under this condition, these authors hypothesized that the resistance to flow had to be located distal to the dilated segment, and was probably caused by a microvascular constriction induced by agents derived from the thrombus. A further example is the study by Pupita et al. [36] who evaluated a group of selected patients with complete occlusion of one coronary branch. In these patients, episodes of resting myocardial ischaemia were explained by increased microvascular tone on the basis of the angiographic disappearance of collateral circulation. Coronary angiography has been also used to study the effect of vasoactive drugs such as serotonin and acetylcholine. McFadden and co-workers [37] analysed coronary angiograms in patients with coronary artery disease before and after intracoronary injection of serotonin. These authors reported, in patients with coronary atherosclerosis, a paradox vasoconstriction in response to serotonin more marked in distal segments of the arterial tree. Accordingly, they speculated that this vasoconstriction might also affect the coronary microvasculature. Similar results have been also obtained with intracoronary acetylcholine [38] . Thus, angiographic studies have been used as indirect evidence of the possible participation of coronary microcirculatory disturbances in the genesis of myocardial ischaemia. However, this technique does not provide any insight into the microvascular segment involved or the mechanism of the disorder. To obtain this insight, the association of angiography with methods able to evaluate regional myocardial perfusion is necessary. Table 2 summarizes the available clinical techniques for measuring coronary blood flow and their main characteristics.
Techniques for measuring coronary blood flow
The most popular methods for measuring blood flow are myocardial scintigraphy, contrast echocardiography, coronary sinus thermodilution, inert gas washout analysis, Doppler-tip devices, positron emission tomography and magnetic resonance imaging, which will be discussed. Myocardial scintigraphy allows the non-invasive visualization of the distribution of myocardial perfusion. The most popular perfusion tracers (i.e. Thallium-201 and technetium-99m tetrofosmin or sestamibi) accumulate in each region of the myocardium in proportion to flow. Accordingly, the imaging of the uptake of these agents provides an accurate estimation of perfusion homogeneity. If perfusion defects are considered as markers of coronary stenosis, myocardial scintigraphy can be documented as a reliable tool in the diagnosis of coronary artery disease; however, when coronary microcirculation is the target of the study this method is hampered by major limitations in the measurement of regional blood flow. In fact, myocardial tracer concentration is related to a variety of factors (injected dose, cardiac output, extraction fraction) which cannot be accurately measured with conventional nuclear imaging. Myocardial scintigraphy therefore can recognize a possible microvascular dysfunction by demonstrating perfusion heterogeneities which are not explained by coronary obstructions [39] . Similarly, in patients with essential hypertension and normal coronary arteries, the presence of perfusion defects can be associated with a reduction in vasodilator reserve evaluated with the Doppler technique [40] . The use of contrast echocardiography is based on the property of air bubbles, which reflect ultrasound when sonicated in a liquid environment. Like microspheres, these bubbles are trapped upstream in the capillary network and can be visualized if imaging is performed before their decay, if the number of bubbles is sufficiently large and if the diameter of each particle is small (10-20 mm) to prevent embolization of large vessels. However, because of these kinetic characteristics, until recently, intracoronary injection was required for myocardial perfusion imaging. Contrast echocardiography has been successfully introduced to evaluate reperfusion in patients submitted to coronary angioplasty in the early phase of acute myocardial infarction, following intracoronary injection [41] . Although preliminary reports appear to be promising, the exact potential of this technique to assess coronary microvascular function or, more ambitiously, to measure regional myocardial blood flow, has not yet been identified. The advantages of high spatial and temporal resolution, lack of radiation exposure and the repeatability of contrast injection render this technique particularly interesting. Recently, major advances have been made which might allow a wider application of this technique. New tracers are being studied to obtain myocardial perfusion imaging with intravenous injection. Moreover, new imaging modalities, such as intermittent imaging or second harmonic imaging, are able to amplify the myocardial perfusion signal, allowing more accurate visualization of myocardial perfusion [42] . A common drawback of myocardial scintigraphy, and so far of contrast echo, is the lack of quantitative information about blood flow [43] . This limitation prevents the utilization of these methods when studying anatomical and functional characteristics of microcirculation. Nevertheless, these techniques enable the presence of a possible microvascular derangement to be detected in large study populations or in selected groups of patients undergoing cardiac catheterization.
Coronary sinus thermodilution is based on the indicator-dilution principle: the continuous infusion of cold saline and the monitoring of blood temperature downstream of the site of injection allows the amount of blood diluting the tracer, i.e. blood flow, to be assessed. If this procedure is performed in the coronary sinus, it allows the amount of blood flowing from the left ventricular myocardium to be calculated [44] [45] . [44, 45] . A further drawback of coronary sinus thermodilution is the lack of regionality. This limitation is particularly relevant under circumstances where the distribution of coronary resistance is inhomogenously distributed throughout the left ventricle, as in patients with coronary artery disease [46] . Inert gas wash-out analysis is also based on the indicator-dilution theory. This approach was originally introduced by Kety and Schmidt [47] for measuring cerebral blood flow and modified by Eckenhoff and co-workers [48] for use in the coronary circulation. Measurement of myocardial blood flow can either be obtained by analysing tracer wash-out in the coronary sinus (obtaining the average specific flow in the left ventricle) [49] or by analysing the residue in each region of the left ventricle [50] . This latter technique imposes the intracoronary injection of a diffusible radioactive tracer (usually Xenon-133) and can provide specific flow values in different regions of the left ventricular myocardium. Although a significant share of our knowledge concerning the pathophysiology of the coronary circulation in humans comes from the application of these techniques, several limitations should be considered. A typical washout curve has at least two slopes (fast and slow): investigators have calculated flow rates either using the fast component, the slow component, or the area under the curve [51] [52] . Regardless of the type of analysis, there is a major limitation under conditions of flow heterogeneity. Since the normoperfused region accumulates more tracer, it is mathematically more represented. As a consequence, this model tends to overestimate the contribution of normoperfused areas to global flow [53] . Additionally, coronary flow higher than 2 ml . g 1 . min 1 cannot be accurately measured, thus hampering the accuracy of flow measurements during pharmacological vasodilation or maximal exercise [54] . Doppler tip devices analyse the shift in ultrasound frequency produced by the movement of red blood cells in the blood stream. The magnitude of the Doppler effect is proportional to blood velocity, therefore the continuous determination of reflected sound frequency allows phasic and average blood flow velocity to be Review 1305 monitored. Several ultrasonic probe configurations are now available. Extravascular probes can be employed at the time of cardiac surgery [55] , while intravascular devices are frequently used at cardiac catheterization [18, 21] . Doppler probes can be mounted either on the tip of a 3F catheter -which can be advanced into the proximal epicardial vessels -or on the top of a guidewire which can pass over the stenosis and reach more distal vascular segments [56] . This makes measurements of blood flow velocity distal to epicardial obstructions feasible. If associated with the measurement of distal coronary pressure, this method might be able to directly quantify coronary resistance offered by segments located distal to a stenosis without the need for assumptions related to stenosis severity and hydraulics [22] . When ultrasonic flowmeters are employed, two important parameters should be considered. First, the magnitude of the Doppler shift is dependent on the angle between the piezoelectric crystal and the blood column, the largest being at 45 . Second, to convert measurements of blood flow velocity to absolute flow, the cross-sectional area of the vessel must be known and the velocity profile relatively flat [57] . This limitation is of less importance when coronary reserve is evaluated as the ratio of maximal to baseline flow velocity. In this setting, epicardial vasomotion is usually blunted by vasorelaxant drugs (usually intracoronary nitrates). Using this pretreatment, the measured shifts in flow velocity directly reflect changes in blood flow. However, this procedure is not feasible when more complex studies of microvascular vasomotion are to be performed. Pre-treatment with nitrates would severely affect the microvascular response to the studied agent. On the other hand, substances active on the coronary microvasculature, also act on large epicardial segments. This means that correct estimation of vessel lumen by quantitative angiography or intravascular echo is essential for the correlation of blood flow and flow velocity under each condition of the study protocol, paying care to exclude the effects of contrast medium on coronary blood flow when angiography is employed.
Positron emission tomography represents an extremely powerful approach, which permits accurate repeated quantitative regional measurements of blood flow per unit volume of tissue in awake humans. In essence, this methodology allows accurate reconstruction of the distribution of a tracer in the system under study, without artefacts due to tissue attenuation as in conventional single photon tomography [58] . Moreover, the availability of positron emitting isotopes, such as oxygen, nitrogen, carbon and fluoride enables tracers whose kinetics are near to optimal to be synthesized. The two most common flow tracers are 13 NAmmonia [59] and 15 O-water [60] . The first molecule is almost completely extracted from the myocardium. Since arterial concentration can easily be measured within the left ventricular chamber during the first pass of ammonia through the systemic circulation, myocardial blood flow can be computed using either compartimental analysis [61] or the first pass approach [62] . Both methods proved to be accurate in assessing regional blood flow, as compared to the gold standard method of labelled microspheres. 15 O-water is a freely diffusible indicator. Basically, with this tracer, measurement of blood flow can be obtained by the analysis of its washout curve. The myocardial extraction of ammonia decreases at high flow; due to this phenomenon a correction becomes necessary when evaluating high blood flow [62] . Additionally, both tracers require a steady state period of at least 1-2 min to allow reliable quantitative measurements. Thus, using positron emission tomography, absolute measurements of regional myocardial blood flow per unit volume of tissue can be non-invasively obtained. However, measurements of rapid changes in myocardial perfusion, as well as the evaluation of phasic flow are not feasible. Although so far the limited spatial resolution of tomographs has prevented analysis of transmural distribution of blood flow, recent advances in technology might allow the inner and outer layers to be differentiated in the near future. Up to now, the non-invasive measurement of regional blood flow with positron emission tomography enabled microvascular function to be characterized in a large number of conditions such as hypercholesterolaemia, early dilated cardiomyopathy, hypertension, syndrome X, and hypertrophic cardiomyopathy. Moreover, in coronary artery disease, this technique allowed vasomotor tone regulation to be verified in the myocardium subtended by stenotic revascularized vessels, by angiographically normal coronary arteries or by collateral branches. Finally a big step forward has been provided by PET studies of blood flow regulation in dysfunctional viable myocardium [6] . Explanted human hearts have been utilized for the study of transmural myocardial blood flow distribution in man. Parodi and colleagues injected a bolus of human albumin microspheres labelled with 99m Tc into the left atrium of patients undergoing heart transplantation [64] . By this method, these authors demonstrated an abnormal endo-epi flow ratio in patients with end-stage ischaemic heart disease.
In recent years, there has been growing interest in using magnetic resonance imaging to evaluate myocardial perfusion in patients [65] . The introduction of subsecond, MRI pulse sequences permits a complete image of the heart to be obtained within a single heart beat. The acquisition of a dynamic series of such images allows the first pass of an intravenously injected bolus of contrast agent to be followed as it passes through the heart cavities and the myocardial tissue. Accordingly, it is possible to generate time-intensity curves in the myocardium, which provide parameters related to myocardial perfusion. This dynamic approach has been successfully used to evaluate myocardial perfusion in animals and in normal humans as well as in patients with coronary artery disease [65] [66] [67] . Finally, magnetic resonance imaging also allows the measurement of flow velocity in the epicardial coronary arteries. The major advantage of this technique in the study of coronary microcirculation is the high spatial resolution and the possibility of obtaining information on both myocardial perfusion and function. The major limitations, so far, seem related to the complexity of both tracer kinetics and signal generation. Because of these limitations, the possibility of magnetic resonance imaging to provide an accurate measurement of myocardial blood flow per gram of tissue in man is still under investigation.
Vasomotor tone regulation
In order to study microvascular tone, physiological as well as pharmacological interventions have been used. The choice of the intervention is strictly dependent on the method for the measurement of flow as well as on the specific target of the study. It is sufficiently clear today that microvascular tone is neither exclusively located at a single level of the coronary tree, such as at the arteriolar level, nor is it under control of a single mechanism. Rather it seems that different transversal portions (levels) of the coronary tree may modulate their tone with different mechanisms. According to this view, total coronary resistance to flow is the result of a large number of in-series and in-parallel resistance values, which may change individually or in families in response to different mechanisms and mediators. These changes may operate in the same direction so as to amplify the final result both in terms of vasodilation or vasoconstriction or, conversely, in the opposite direction with a variable integrated result on flow. To further complicate this issue, additional variables should be considered related to the route of drug administration and the duration of their effect. Direct intracoronary drug injection prevents gross changes in systemic haemodynamics, which might per se affect coronary resistance. Accordingly, this route permits the use of drugs not suitable for intravenous injection, such as papaverine [18] or acetylcholine [38] . On the other hand, systemic administration makes a non-invasive approach possible, thus allowing repeated measurements in follow-up studies. In order to study the so-called 'metabolic' component of coronary resistance, coupled with myocardial energy demand, cardiac work may be increased by atrial pacing [68] , exercise [69] or by the administration of dobutamine [70] . Unfortunately, the large majority of methods used for increasing cardiac work also induce important neurohumoral changes which might per se affect coronary microvascular tone. A similar consideration holds for inotropic drugs, which can exert direct actions on coronary smooth muscle cells [71] . Moreover, when the metabolic component of vascular tone is analysed, it becomes essential to accurately assess myocardial oxygen consumption. Due to its simple acquisition, rate-pressure product is frequently used as 'the' clinical index of oxygen demand, although it neglects wall stress and contractility [72] . In order to assess endothelial function, several substances have been evaluated in different vascular districts: acetylcholine [38] , -arginine [73] , serotonin [37, 74] , neuropeptide Y [75] , atrial natriuretic peptide [76] and substance P [77] . Most of these substances can induce vasodilation only in the presence of an intact endothelium, while their effects may be reduced or even reversed in the presence of endothelial damage. Most of the studies dealing with the endothelial control of vascular tone have been concentrated on large conduit arteries [78] . Only a few studies have addressed the role of endothelium-dependent control of microvascular tone. These studies have demonstrated that endothelium-dependent mechanisms are operative in small vessels as well.
In patients with mild non-obstructive coronary atherosclerosis, Zeiher et al. [38] , using a Doppler flowmeter associated with quantitative coronary angiography, reported that intracoronary injection of acetylcholine increases myocardial blood flow by much as 140% in healthy subjects. In contrast, in patients with coronary atherosclerosis, the increase was markedly limited to 12%, with only a minor reduction in coronary reserve (3·61 vs 4·65). These findings document the possibility of selective alteration of endothelial control of vascular tone in the absence of significant impairment of the adenosine mediated pathway. Golino and co-workers [79] , using the same techniques, documented absolute vasoconstriction, rather than reduced vasodilation induced by serotonin in the distal segments of the atherosclerotic coronary tree. Recently, a significant correlation between exercise-induced ischaemia and reduced response to acetylcholine has been demonstrated [80] . These studies represent a major advance in our understanding of the role of the endothelium in the regulation of the vascular tone. Nevertheless, these data should be interpreted with caution, since the exact role of all these agents and their interactions have not been conclusively established. Although it is generally accepted that acetylcholine produces endothelial mediated vasodilation as well as a direct vasoconstrictor effect on the coronary smooth muscle, the net result of these opposing effects depends on the particular coronary segment and on the applied dose. In large conduit arteries, it has been shown that progressively increasing doses of acetylcholine may produce dilation at low dose, in contrast to vasoconstriction at high dose [81] . More recently, however, it has been shown that the response to substance P, a pure EDRF stimulator, does not always mimic the lack of a vasodilating response to acetylcholine, suggesting that the latter response cannot be used as a reliable index of altered EDRF release [82] . So far, it has not been conclusively established whether these differences are also present in the coronary microvasculature.
In conclusion, some information on microvascular vasomotor tone and its different components can be obtained by the measurement of coronary blood flow and its response to various interventions. However, it should be realised that this approach is affected by several limitations, due not only to technical problems in obtaining quantitative measurements of regional myocardial blood flow, but also to our primitive knowledge
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on sites and types of vascular tone controls and to the difficult (if not impossible) direct access to intramural vessels.
Extramural forces
Extramural forces strongly affect coronary blood flow, its transmural distribution and the exchange of water and solutes between blood and tissue at the capillary level. Unfortunately, even in experimental cardiology, no method of measuring intramyocardial pressure is completely satisfactory. There is general agreement that intramyocardial pressure during systole (and possibly in diastole) is higher in the deeper as compared to outer layers of the left ventricle, reaching values even greater than the intracavitary ones [83 . Nevertheless, a precise definition of the transmural gradient of intramyocardial pressure under a variety of conditions is not available.
In the clinical setting, this uncertainty is still more evident, and no method is available for a direct measurement of intramyocardial tissue pressure. Due to the larger diastolic component of phasic coronary blood flow, left ventricular end-diastolic pressure has been suggested as an index of the average intramyocardial pressure opposing coronary flow. In agreement with this concept, in hypertensive patients, Opherk and co-workers showed a significant inverse correlation between left ventricular end-diastolic pressure and the impairment in coronary reserve [84] . However, other reports on this topic showed different results [85] and the use of left ventricular enddiastolic pressure as an index of intramyocardial pressure is a matter of controversy.
As a matter of fact, it should be considered that diastolic wall tension rather than diastolic intraventricular pressure should more accurately reflect diastolic intramyocardial pressure [86] . Diastolic wall tension is proportional to end-diastolic pressure as well as to left ventricular volume and wall thickness. As a consequence, although elevated values of left ventricular end-diastolic pressure can be associated with an increase in intramyocardial pressure in several pathological conditions, the scatter of this relationship prevents a reliable estimate of intramyocardial pressure.
An alternative index of intramyocardial pressure is the critical closing pressure of coronary circulation, i.e. the perfusion pressure level at which flow stops. Although in humans this value cannot be directly measured, theoretically, it can be obtained from the pressure-flow relationship under conditions of maximal vasodilation, as previously discussed in the minimal resistance section [22, [30] [31] [32] [33] [34] . Although few data are available in the literature on this approach, the possibility to monitor coronary flow velocity by Doppler catheter makes this approach feasible in the clinical setting.
Blood-tissue exchange
The ultimate purpose of the coronary microvasculature is fulfilled in the capillaries where the exchange of substances between blood and tissue takes place across the capillary wall, which separates plasma and the interstitial fluid. Failure to identify an anatomical 'precapillary sphincter' and the notion that capillaries are a relatively rigid structure support the hypothesis that capillary function is mainly regulated by the tonus in the small intra-myocardial arterioles [87] [88] [89] . In view of the importance of this part of the coronary circulation, it is surprising how little information the literature provides about the function of the capillaries in the human heart. This is probably due to the condition of blood flow heterogeneity which impose major limitations to all available techniques for quantitative measurements of capillary permeability.
A significant share of our knowledge of myocardial capillary function comes from animal experiments. During normal physiological conditions, 2-50% of hydrophilic molecules traverse the capillary in a single transit, i.e. diffusion-limited transport [90, 91] . Most hydrophilic solutes are mainly restricted to paracellular channels with an equivalent effective capillary pore radius of about 150 A r [91] . Lipid-soluble molecules, gases such as oxygen and carbon dioxide and to some extent water diffuse through the entire endothelial surface which ensure a very fast transfer and are usually equilibrated in a single capillary passage, i.e. flow limited transport [90] . Quantitative measurements of transcapillary exchange of hydrophilic molecules can be obtained from the Renkin formulation of the Fick's diffusion equation:
PS= f (pl) .K.In(1-E), (ml.(100g.min) 1 ) [92] where PS is the permeability-surface area product, f (pl) is plasma flow rate, K is a constant for the conversion of ml plasma to ml plasma-water, taking the molecular charge in consideration, and E is the capillary extraction fraction of the test molecule.
In order to calculate the diffusion permeability coefficient, P, an estimate of the average capillary surface area, S, is necessary. Capillary permeability has frequently been determined in dog experiments under normal and pathophysiological conditions. Commonly used methods are based on indicator diffusion kinetics [90] . To determine capillary permeability on the basis of organ measurements, several assumptions are made about the individual tissue region and the interaction between neighbouring regions. Often these assumptions cannot be evaluated directly [90, 93] . Assumption of systemic steady state is elementary. Unfortunately, most of the indicator diffusion methods cannot be applied in man because of practical and methodological problems.
The single injection residue detection method is an alternative technique for measurement of capillary permeability and has been applied to the human heart [94] . The great methodological advantage is simplicity. Following intra-coronary bolus injection of a gammaemitting indicator ( 99m Tc-DTPA) and external residue detection a recorded activity curve as a function of time plotted in a semilogarithmic diagram is obtained (Fig. 3) . The injected indicator serves as its own intravascular reference and the curve is analysed using black box indicator kinetic principles [90, 93, 95] . It is assumed that it is possible to separate the recorded residue function into two fractions, the extracted and the transmitted parts. The residue washout curve is only monoexponential for a limited period of currently matching flow and extraction arises. It is also assumed that re-circulation of the indicator is negligible, and that myocardial blood volume value is known or can be determined. At present, data on the magnitude of vascular volume in the human myocardium have been obtained in only a few studies [96] . We have estimated a value of 13·6 ml 100 g 1 in dog hearts [97] . This value is higher than the value used in PET studies, which will tend to increase the blood flow values obtained by the single injection residue detection method. Furthermore, plasma flow rate (f (pl) ), and capillary surface area, S, must be constant during the measurements. However, this is often difficult to ascertain, especially in the human heart where it is impossible to monitor blood flow over a longer period.
It is well known that capillary extraction fraction decreases with increasing plasma flow rate. This important relationship limits the single injection residue detection method, which can only be used at steady state blood flow conditions. Capillary data obtained by the single injection residue detection technique in the human heart of patients with angiographically normal coronary arteries has been compared to capillary determinations on canine heart and a good correlation was found [94] .
The single injection residue detection method is an invasive technique. This is usually considered a disadvantage due to possible influences caused by the invasive procedure. In patients with ischaemic heart disease or left ventricular hypertrophy no capillary permeability data are available. This is primarily due to local, spatial and transmural heterogeneity of plasma flow rate which seems to invalidate all available techniques for quantitative determination of capillary permeability.
It is clear today that the endothelial cells are not simple passive elements in the exchange of solutes between the intravascular and the interstitial space. Under pathological conditions, such as inflammation, endothelial cells may actively control vascular permeability. This happens when chemical mediators from storage in the tissue specifically activate the endothelium and within seconds completely change the permeability characteristics of the microvascular wall [98] . Whether this also takes place in the human heart is completely unknown. However, the capillary leak associated with cardiopulmonary bypass which results in increased content of water in the tissues, indirectly shows that such a change in capillary permeability may occur in the human heart as well [99] .
Metabolic control of microvascular tone
In the previous paragraphs, the strict link between myocardial metabolism and microcirculatory tone has been underlined. Accordingly, a correct interpretation of flow measurements often requires the knowledge of myocardial oxygen consumption, particularly when autoregulation is preserved.
Myocardial energy demand can be evaluated in man either invasively by measuring flow and arterovenous differences in metabolites [100] , or non-invasively by measuring myocardial uptake and washout of radioactive tracers using position emission tomography.
Invasive assessment of myocardial metabolism requires catheterization of the coronary sinus. This technique allows the measurement of coronary blood flow (either by thermodilution or by inert gas technique) and of arterovenous differences in various substances such as O 2 , CO 2 , glucose, lactate, free fatty acid and hormones. In fact, with this technique myocardial uptake and extraction fraction can be calculated for any given substance. When radioactive metabolites are employed, more detailed information can be obtained regarding distribution volumes, net extraction and net clearance. As previously discussed in the section on blood flow measurement by the thermodilution technique, coronary sinus catheterization provides only average values relative to the drained territory with major limitations under conditions of flow heterogeneity. In the presence of metabolic inhomogeneity, measurements of arterovenous differences will mostly be representative of the better perfused myocardial regions with the highest flow values. This limitation can be overcome by the use of positron emission tomography. The positron emitting nuclides carbon-11, nitrogen-13 and oxygen-15 can be introduced in a large series of molecules entering metabolic pathways. Several tracers are used for non-invasive evaluation of regional myocardial metabolism. 18 Ffluorodeoxyglucose is a glucose analogue that competes with glucose for transmembrane transport and phosphorylation by hexokinase reaction. Fluorodeoxyglucose 6-phosphate, the phosphorylated product, is not further metabolized and accumulates in the cytosol proportionately to exogenous glucose utilization [101] [102] [103] . Accordingly the net uptake of the tracer is proportional to the uptake of glucose.
To quantify myocardial oxygen utilization, 15 Ooxygen has been proposed as a suitable tracer since it permits the delineation of oxidative metabolism [104, 105] . However, this tracer has so far not been extensively used and its employment tracer awaits further evaluation. An alternative method to quantify oxygen consumption is the evaluation of the citric acid cycle using 11 C-acetate. Once inside the myocyte this tracer directly enters the mitochondria and the citric acid cycle participates as C-11 actyl-COA. 11 C activity is cleared from the heart in the form of 11 C-carbondioxide, thus reflecting the citric acid cycle flux. In animal studies, a close correlation between 11 C clearance rate and myocardial oxygen consumption has been reported over a wide range of physiological conditions [106, 107] . This observation was confirmed in humans by studies comparing C-11 acetate clearance rates with other parameters of oxygen consumption [108, 109] . Altogether, both invasive techniques and positron emission tomography enable myocardial metabolism and myocardial blood flow, two fundamental parameters for the understanding of microcirculation pathophysiology, to be studied. Several issues remain unsolved relative to the match between metabolic demand and myocardial blood flow. The most important question arises from the frequent observation of severely reduced blood flow associated with maintained metabolic activity: in this case it is not always clear whether this condition represents a myocardial adaptation to reduced perfusion or vice versa. This issue is of great relevance in those clinical syndromes characterized by left ventricular dysfunction. Although for many years, the myocardium has been considered not to be able to regulate its own metabolic demand, recent studies support this possibility [110] and show that the myocardium can actively down-regulate its own oxygen consumption below the actual flow availability, thus restoring a residual vasodilating capability [111] . Other authors reported a paradoxical vasoconstrictor response to reduced pressure [112] , such as in the vascular bed downstream of a severely stenotic coronary artery. According to these findings, a reduced blood flow, in the presence of a residual coronary reserve [113, 114] , could reflect an inappropriate vasoconstriction as well as the physiological vascular response to an active downregulation of metabolic demand, unless evidence of demand-supply mismatch is evident. As indexes of a demand-supply mismatch, several authors have utilized the decrease in either lactate extraction or in oxygen saturation of coronary sinus venous blood. These indexes appear theoretically sound; however, it should be considered that while their abnormalities are consistent with a supply-demand imbalance, their normality cannot exclude its occurrence if heterogeneously distributed in the drained territory. Moreover, normal metabolic indexes in the coronary sinus blood do not elucidate whether the reduced metabolic demand (and wall motion) reflects a primary myocardial downregulation or rather a myocardial adaptation to the reduced flow supply caused by an excessive vascular tone. The identification of new markers of supplydemand imbalance suitable for imaging might allow a more profound insight into the interaction between cardiac microcirculation and tissue metabolism in the future.
